LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
12.31
+0.26 (2.16%)
At close: Oct 31, 2025, 4:00 PM EDT
12.30
-0.01 (-0.08%)
After-hours: Oct 31, 2025, 4:31 PM EDT
LENSAR Revenue
LENSAR had revenue of $13.94M in the quarter ending June 30, 2025, with 10.28% growth. This brings the company's revenue in the last twelve months to $58.36M, up 29.34% year-over-year. In the year 2024, LENSAR had annual revenue of $53.49M with 26.87% growth.
Revenue (ttm)
$58.36M
Revenue Growth
+29.34%
P/S Ratio
2.42
Revenue / Employee
$416,886
Employees
140
Market Cap
146.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 53.49M | 11.33M | 26.87% |
| Dec 31, 2023 | 42.16M | 6.81M | 19.25% |
| Dec 31, 2022 | 35.36M | 899.00K | 2.61% |
| Dec 31, 2021 | 34.46M | 8.08M | 30.62% |
| Dec 31, 2020 | 26.38M | -4.15M | -13.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
LNSR News
- 2 months ago - LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - LENSAR Reports Second Quarter 2025 Results and Provides Business Update - GlobeNewsWire
- 5 months ago - LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR - Business Wire
- 6 months ago - LENSAR Reports First Quarter 2025 Results and Provides Business Update - GlobeNewsWire
- 8 months ago - LENSAR, Inc. (LNSR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 8 months ago - LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update - GlobeNewsWire
- 9 months ago - LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025 - GlobeNewsWire
- 9 months ago - Medical Devices Firm Lensar Surges Ahead On Robotic Technology - Seeking Alpha